AGRO vs HLF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AGRO's Piotroski F-Score of 4/9 indicates weak financial health, signaling deteriorating operational efficiency and potential distress. The absence of an Altman Z-Score raises red flags for bankruptcy risk, especially given a high debt/equity ratio of 1.12 and negative earnings growth of -65.6% YoY. Despite a seemingly attractive Graham Number of $8.42, the current price of $12.45 trades at a significant premium, supported only by speculative growth expectations. The stock's technical trend is bearish (10/100), and analyst consensus is neutral (hold), with a target price below current levels. The dividend payout ratio of 149.15% is unsustainable, further undermining long-term viability.
HLF presents a complex profile characterized by a strong Piotroski F-Score of 7/9, indicating operational improvement, contrasted against a critical structural red flag: a negative Price/Book ratio (-3.30) suggesting negative shareholders' equity. While valuation metrics are highly attractive with a P/E of 7.48 and a PEG of 0.61, these are overshadowed by a severe -53.3% collapse in year-over-year earnings growth. The stock is currently trading at $16.46, slightly above its growth-based intrinsic value of $15.40. Consequently, the company appears to be a deep-value play with significant balance sheet risks and inconsistent earnings quality.
Compare Another Pair
Related Comparisons
AGRO vs HLF: Head-to-Head Comparison
This page compares Adecoagro S.A. (AGRO) and Herbalife Ltd. (HLF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.